Milestone Pharmaceuticals (MIST) Treasury Shares (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Treasury Shares of $2.3 million for Q1 2026, up 142.42% on a QoQ basis from $950700.0 in Q4 2025, and up 133.07% year-over-year from $988850.0 in Q1 2025.
Milestone Pharmaceuticals (MIST) Treasury Shares (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Treasury Shares history runs 5 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- Quarterly Treasury Shares rose 133.07% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 133.07% YoY) and the FY2025 annual result came in at $950700.0, up 2.89% from the prior year.
- Treasury Shares was $2.3 million for Q1 2026 at Milestone Pharmaceuticals, up from $950700.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $2.3 million in Q1 2026 and bottomed at $924000.0 in Q2 2024.
- A 3-year average of $1.2 million and a median of $937350.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2025 — Treasury Shares rose 2.89% — and 2026, when it surged 133.07%.
- Milestone Pharmaceuticals' Treasury Shares stood at $924000.0 in 2024, then increased by 2.89% to $950700.0 in 2025, then surged by 142.42% to $2.3 million in 2026.
- Business Quant data shows MIST's Treasury Shares at $2.3 million in Q1 2026, $950700.0 in Q4 2025, and $988850.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 950,700.00 |
| Dec 31, 2025 | 950,700.00 |
| Mar 31, 2025 | 988,850.00 |
| Mar 31, 2025 | 988,850.00 |
| Dec 31, 2024 | 924,000.00 |
| Dec 31, 2024 | 924,000.00 |
| Sep 30, 2024 | 924,000.00 |
| Sep 30, 2024 | 924,000.00 |
| Jun 30, 2024 | 924,000.00 |
| Jun 30, 2024 | 924,000.00 |
| Jun 30, 2019 | -2.83 Mn |
| Jun 30, 2019 | -2.83 Mn |
| Mar 31, 2019 | 2.44 Mn |
| Mar 31, 2019 | 2.44 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Sep 30, 2018 | 3.79 Mn |
| Sep 30, 2018 | 3.79 Mn |